Item request has been placed!
×
Item request cannot be made.
×

PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) (PRO-MERIT)
Item request has been placed!
×
Item request cannot be made.
×

- المصدر:First-in-human, Dose Titration and Expansion Trial to Evaluate Safety, Immunogenicity and Preliminary Efficacy of W_pro1 (BNT112) Monotherapy and in Combination With Cemiplimab in Patients With Prostate Cancer
No Comments.